Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lactibiane Tolerance®, a Multistrain Probiotic, to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) Patients: an Open-label, Single-center, Proof-of-concept, Pilot Study

NCT04898257 is registered in ClinicalTrials.gov with Larena SAS as lead sponsor.

NCT NCT04898257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lactibiane Tolerance®, a Multistrain Probiotic, to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) Patients: an Open-label, Single-center, Proof-of-concept, Pilot Study
Lead sponsor
Larena SAS
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2018
Completion date
November 25, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome